BIOASTER
Thomas Leicht currently serves as the Business and Partnership Development lead for the Microbiome Program at BIOASTER since March 2023. Prior to this role, Thomas held a decade-long position as Director of Business Development at Laboratoires Bailleul, overseeing portfolio management, business development, alliance management, and strategy for global project execution. In previous roles, Thomas directed regulatory affairs and international regulatory activities for various regions, including Africa, the Middle East, and Asia, while working with sanofi-aventis and contributing to registration strategies across multiple markets. Thomas began a career in regulatory affairs as a trainee at Pierre Fabre and holds a Master's degree in Community Laws and Drug Regulations and a Bachelor's degree in Biochemistry from Université Louis Pasteur in Strasbourg.
This person is not in any offices
BIOASTER
1 followers
BIOASTER Technology Research Institute (TRI) is working to develop an unique technological and innovative model to support the latest challenges in microbiology, in particular to : -Fight antimicrobials resistance. -Improve vaccines safety and efficacy. -Quickly diagnose infections at patient bedside. -take full advantage to human and animal microbiota. In order to overcome technological bottlenecks and explore new avenues, BIOASTER is leading collaborative projects that bring together academics, start-ups, SMEs and industrial groups around key thematic and technology units. Each project strives on academic research excellence and is undertaken by a team of high-level experts and engineers, which benefits from state-of-the-art equipment, technological infrastructures. BIOASTER, an independent non-profit organization, is one of 8 French TRIs created in 2012 on the initiative of the French Government through the “Investments for the Future” program. The two historical founders are Lyonbiopôle (a biocluster, the one-stop shop for healthcare innovation in Rhône-Alpes, France) and the Institut Pasteur in Paris. They were joined from the beginning by the CNRS, the INSERM, the CEA, Mérieux Institute, Danone Nutricia Research and Sanofi Pasteur -and newly joined by bioMérieux- to create a unique Technology Institute dedicated to infectious diseases and microbiology in health. The Institute benefits from the support of Lyon Métropole and the Region Auvergne Rhône Alpes and the dynamism of a group of 40 SMEs in the Lyon and Paris regions. Located in Lyon and Paris, BIOASTER has more than 100 employees including 80 world-class scientists and engineers originating from 16 different countries. More information on www.bioaster.org